- Report
- July 2024
- 182 Pages
Global
From €3950EUR$4,500USD£3,437GBP
- Report
- February 2024
- 175 Pages
Global
From €3950EUR$4,500USD£3,437GBP
- Report
- November 2023
- 78 Pages
France
From €3072EUR$3,500USD£2,673GBP
- Report
- November 2023
- 190 Pages
Global
From €3950EUR$4,500USD£3,437GBP
- Report
- November 2023
- 78 Pages
Germany
From €3072EUR$3,500USD£2,673GBP
- Report
- December 2022
- 115 Pages
Global
From €3950EUR$4,500USD£3,437GBP
- Report
- May 2024
- 182 Pages
Global
From €3950EUR$4,500USD£3,437GBP
- Report
- May 2024
- 182 Pages
Global
From €3950EUR$4,500USD£3,437GBP
- Report
- December 2024
- 175 Pages
Global
From €4389EUR$5,000USD£3,818GBP
- Report
- November 2024
- 338 Pages
Global
From €4389EUR$5,000USD£3,818GBP
- Report
- May 2024
- 279 Pages
Global
From €4389EUR$5,000USD£3,818GBP
- Report
- January 2024
- 200 Pages
Global
From €4389EUR$5,000USD£3,818GBP
- Report
- June 2021
Global
From €3511EUR$4,000USD£3,055GBP
- Report
- November 2023
- 120 Pages
Asia Pacific
From €3511EUR$4,000USD£3,055GBP
- Report
- January 2025
- 175 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Report
- November 2023
- 77 Pages
France
From €3072EUR$3,500USD£2,673GBP
- Report
- December 2024
- 200 Pages
Global
From €3292EUR$3,750USD£2,864GBP
- Report
- December 2024
- 200 Pages
Global
From €3292EUR$3,750USD£2,864GBP
- Report
- December 2024
- 200 Pages
Global
From €3292EUR$3,750USD£2,864GBP
- Report
- October 2024
- 200 Pages
Global
From €3292EUR$3,750USD£2,864GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more